TAK: Takeda Pharmaceutical Co Ltd Financial Statements
Balance sheet, income statement, and cash flow statements for Takeda Pharmaceutical Co Ltd (TAK).
¥47.14B Market Cap.
TAK Market Cap. (MRY)
TAK Shares Outstanding (MRY)
TAK Assets (MRY)
Total Assets
¥14.25T
Total Liabilities
¥7.31T
Total Investments
¥382.40B
TAK Income (MRY)
Revenue
¥4.58T
Net Income
¥107.93B
Operating Expense
¥2.66T
TAK Cash Flow (MRY)
CF Operations
¥1.06T
CF Investing
-¥367.06B
CF Financing
-¥751.42B
TAK Balance Sheet (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total Assets | ¥14,248,344,000,000 (-5.70%) | ¥15,108,792,000,000 (8.25%) | ¥13,957,750,000,000 (5.92%) | ¥13,178,018,000,000 (2.06%) |
Assets Current | ¥2,521,192,000,000 (-1.46%) | ¥2,558,580,000,000 (6.70%) | ¥2,397,956,000,000 (-7.54%) | ¥2,593,642,000,000 (-4.40%) |
Assets Non-Current | ¥11,727,152,000,000 (-6.56%) | ¥12,550,212,000,000 (8.57%) | ¥11,559,794,000,000 (9.22%) | ¥10,584,376,000,000 (3.77%) |
Goodwill & Intangible Assets | ¥8,955,990,000,000 (-7.52%) | ¥9,684,749,000,000 (6.89%) | ¥9,060,380,000,000 (10.14%) | ¥8,226,293,000,000 (3.57%) |
Shareholders Equity | ¥6,935,084,000,000 (-4.65%) | ¥7,273,264,000,000 (14.47%) | ¥6,354,122,000,000 (11.81%) | ¥5,683,019,000,000 (9.86%) |
Property Plant & Equipment Net | ¥1,968,209,000,000 (-1.08%) | ¥1,989,777,000,000 (17.65%) | ¥1,691,229,000,000 (6.85%) | ¥1,582,800,000,000 (8.86%) |
Cash & Equivalents | ¥385,113,000,000 (-15.88%) | ¥457,800,000,000 (-14.19%) | ¥533,530,000,000 (-37.21%) | ¥849,695,000,000 (-12.06%) |
Accumulated Other Comprehensive Income | ¥0 (0%) | ¥0 (0%) | ¥0 (0%) | ¥0 (0%) |
Deferred Revenue | ¥0 (0%) | ¥0 (0%) | ¥0 (0%) | ¥0 (0%) |
Total Investments | ¥382,402,000,000 (-14.20%) | ¥445,697,000,000 (11.69%) | ¥399,031,000,000 (12.26%) | ¥355,438,000,000 (-7.67%) |
Investments Current | ¥20,476,000,000 (35.70%) | ¥15,089,000,000 (-25.21%) | ¥20,174,000,000 (-20.28%) | ¥25,305,000,000 (-30.86%) |
Investments Non-Current | ¥361,926,000,000 (-15.95%) | ¥430,608,000,000 (13.66%) | ¥378,857,000,000 (14.76%) | ¥330,133,000,000 (-5.23%) |
Inventory | ¥1,217,349,000,000 (0.62%) | ¥1,209,869,000,000 (22.65%) | ¥986,457,000,000 (15.62%) | ¥853,167,000,000 (13.17%) |
Trade & Non-Trade Receivables | ¥709,465,000,000 (6.14%) | ¥668,403,000,000 (2.92%) | ¥649,429,000,000 (-6.78%) | ¥696,644,000,000 (-11.04%) |
Trade & Non-Trade Payables | ¥475,541,000,000 (-13.15%) | ¥547,521,000,000 (-15.67%) | ¥649,233,000,000 (25.75%) | ¥516,297,000,000 (50.16%) |
Accumulated Retained Earnings (Deficit) | ¥1,187,586,000,000 (-14.64%) | ¥1,391,203,000,000 (-9.73%) | ¥1,541,146,000,000 (4.15%) | ¥1,479,716,000,000 (-2.00%) |
Tax Assets | ¥386,534,000,000 (-8.64%) | ¥423,072,000,000 (6.23%) | ¥398,267,000,000 (2.05%) | ¥390,272,000,000 (1.79%) |
Tax Liabilities | ¥168,967,000,000 (-25.91%) | ¥228,064,000,000 (-56.77%) | ¥527,555,000,000 (-21.74%) | ¥674,063,000,000 (-6.61%) |
Total Debt | ¥5,285,285,000,000 (-6.87%) | ¥5,675,006,000,000 (11.23%) | ¥5,102,147,000,000 (1.83%) | ¥5,010,425,000,000 (-7.23%) |
Debt Current | ¥768,059,000,000 (50.40%) | ¥510,672,000,000 (-2.75%) | ¥525,137,000,000 (31.26%) | ¥400,064,000,000 (48.06%) |
Debt Non-Current | ¥4,517,226,000,000 (-12.53%) | ¥5,164,334,000,000 (12.83%) | ¥4,577,010,000,000 (-0.72%) | ¥4,610,361,000,000 (-10.15%) |
Total Liabilities | ¥7,312,365,000,000 (-6.67%) | ¥7,834,788,000,000 (3.05%) | ¥7,603,078,000,000 (1.45%) | ¥7,494,495,000,000 (-3.11%) |
Liabilities Current | ¥2,506,521,000,000 (8.36%) | ¥2,313,103,000,000 (-6.80%) | ¥2,481,940,000,000 (15.67%) | ¥2,145,730,000,000 (21.01%) |
Liabilities Non-Current | ¥4,805,844,000,000 (-12.96%) | ¥5,521,685,000,000 (7.82%) | ¥5,121,138,000,000 (-4.26%) | ¥5,348,765,000,000 (-10.28%) |
TAK Income Statement (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Revenues | ¥4,581,551,000,000 (7.45%) | ¥4,263,762,000,000 (5.87%) | ¥4,027,478,000,000 (12.85%) | ¥3,569,006,000,000 (11.61%) |
Cost of Revenue | ¥1,580,217,000,000 (10.76%) | ¥1,426,678,000,000 (14.68%) | ¥1,244,072,000,000 (12.40%) | ¥1,106,846,000,000 (11.32%) |
Selling General & Administrative Expense | ¥1,104,766,000,000 (4.83%) | ¥1,053,819,000,000 (5.67%) | ¥997,309,000,000 (12.52%) | ¥886,361,000,000 (1.22%) |
Research & Development Expense | ¥730,227,000,000 (0.04%) | ¥729,924,000,000 (15.25%) | ¥633,325,000,000 (20.38%) | ¥526,087,000,000 (15.41%) |
Operating Expenses | ¥2,658,747,000,000 (1.36%) | ¥2,623,008,000,000 (14.40%) | ¥2,292,900,000,000 (14.57%) | ¥2,001,315,000,000 (18.12%) |
Interest Expense | ¥210,065,000,000 (-4.45%) | ¥219,850,000,000 (29.55%) | ¥169,698,000,000 (1.86%) | ¥166,607,000,000 (-32.99%) |
Income Tax Expense | ¥66,941,000,000 (173.23%) | -¥91,406,000,000 (-257.46%) | ¥58,052,000,000 (-19.82%) | ¥72,405,000,000 (828.71%) |
Net Loss Income from Discontinued Operations | ¥0 (0%) | ¥0 (0%) | ¥0 (0%) | ¥0 (0%) |
Consolidated Income | ¥108,143,000,000 (-25.00%) | ¥144,197,000,000 (-54.52%) | ¥317,038,000,000 (37.74%) | ¥230,166,000,000 (-38.81%) |
Net Income to Non-Controlling Interests | ¥215,000,000 (65.38%) | ¥130,000,000 (519.05%) | ¥21,000,000 (-80.37%) | ¥107,000,000 (-35.54%) |
Net Income | ¥107,928,000,000 (-25.08%) | ¥144,067,000,000 (-54.56%) | ¥317,017,000,000 (37.80%) | ¥230,059,000,000 (-38.81%) |
Preferred Dividends Income Statement Impact | ¥0 (0%) | ¥0 (0%) | ¥0 (0%) | ¥0 (0%) |
Net Income Common Stock | ¥107,928,000,000 (-25.08%) | ¥144,067,000,000 (-54.56%) | ¥317,017,000,000 (37.80%) | ¥230,059,000,000 (-38.81%) |
Weighted Average Shares | ¥1,585,179,249 (1.04%) | ¥1,568,906,327 (1.20%) | ¥1,550,360,779 (-0.83%) | ¥1,563,358,159 (0.36%) |
Weighted Average Shares Diluted | - | - | - | - |
Earning Before Interest & Taxes (EBIT) | ¥384,934,000,000 (41.25%) | ¥272,511,000,000 (-49.98%) | ¥544,767,000,000 (16.14%) | ¥469,071,000,000 (-23.69%) |
Gross Profit | ¥3,001,334,000,000 (5.79%) | ¥2,837,084,000,000 (1.93%) | ¥2,783,406,000,000 (13.05%) | ¥2,462,160,000,000 (11.74%) |
Operating Income | ¥342,587,000,000 (60.03%) | ¥214,076,000,000 (-56.36%) | ¥490,506,000,000 (6.44%) | ¥460,845,000,000 (-9.51%) |
TAK Cash Flow Statement (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Net Cash Flow from Investing | -¥367,060,000,000 (20.87%) | -¥463,862,000,000 (23.59%) | -¥607,102,000,000 (-206.42%) | -¥198,125,000,000 (-150.35%) |
Net Cash Flow from Financing | -¥751,425,000,000 (-112.02%) | -¥354,416,000,000 (50.02%) | -¥709,148,000,000 (33.74%) | -¥1,070,265,000,000 (1.66%) |
Net Cash Flow from Operations | ¥1,057,182,000,000 (47.58%) | ¥716,344,000,000 (-38.41%) | ¥1,163,122,000,000 (-7.95%) | ¥1,263,528,000,000 (4.20%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -¥61,303,000,000 (39.86%) | -¥101,934,000,000 (69.94%) | -¥339,094,000,000 (-133.40%) | -¥145,285,000,000 (-145.96%) |
Net Cash Flow - Business Acquisitions and Disposals | ¥77,243,000,000 (287.01%) | ¥19,959,000,000 (150.80%) | ¥7,958,000,000 (137.06%) | -¥21,476,000,000 (-104.05%) |
Net Cash Flow - Investment Acquisitions and Disposals | -¥81,306,000,000 (-662.83%) | ¥14,446,000,000 (-7.78%) | ¥15,665,000,000 (30.75%) | ¥11,981,000,000 (-80.80%) |
Capital Expenditure | -¥232,501,000,000 (-39.38%) | -¥166,814,000,000 (-19.41%) | -¥139,695,000,000 (-15.03%) | -¥121,437,000,000 (-87.54%) |
Issuance (Repayment) of Debt Securities | -¥314,314,000,000 (-20874.22%) | ¥1,513,000,000 (100.53%) | -¥285,071,000,000 (52.53%) | -¥600,477,000,000 (9.09%) |
Issuance (Purchase) of Equity Shares | -¥51,860,000,000 (-2129.58%) | -¥2,326,000,000 (91.36%) | -¥26,929,000,000 (65.27%) | -¥77,531,000,000 (-3521.25%) |
Payment of Dividends & Other Cash Distributions | -¥302,498,000,000 (-5.33%) | -¥287,188,000,000 (-2.78%) | -¥279,416,000,000 (1.50%) | -¥283,665,000,000 (-0.11%) |
Effect of Exchange Rate Changes on Cash | -¥11,385,000,000 (-143.45%) | ¥26,204,000,000 (14.28%) | ¥22,929,000,000 (-20.27%) | ¥28,758,000,000 (130.05%) |
Share Based Compensation | ¥72,867,000,000 (2.82%) | ¥70,871,000,000 (16.81%) | ¥60,672,000,000 (39.88%) | ¥43,374,000,000 (15.16%) |
Depreciation Amortization & Accretion | ¥761,396,000,000 (4.59%) | ¥728,002,000,000 (9.57%) | ¥664,400,000,000 (13.93%) | ¥583,151,000,000 (4.20%) |
TAK Financial Metrics (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Gross Margin | 65.50% (-1.50%) | 66.50% (-3.76%) | 69.10% (0.14%) | 69.00% (0.15%) |
Profit Margin | 2.40% (-29.41%) | 3.40% (-56.96%) | 7.90% (23.44%) | 6.40% (-45.76%) |
EBITDA Margin | 25.00% (6.38%) | 23.50% (-21.67%) | 30.00% (1.69%) | 29.50% (-19.62%) |
Return on Average Equity (ROAE) | 1.50% (-28.57%) | 2.10% (-58.00%) | 5.00% (16.28%) | 4.30% (-45.57%) |
Return on Average Assets (ROAA) | 0.70% (-30.00%) | 1.00% (-56.52%) | 2.30% (27.78%) | 1.80% (-40.00%) |
Return on Sales (ROS) | 8.40% (31.25%) | 6.40% (-52.59%) | 13.50% (3.05%) | 13.10% (-31.77%) |
Return on Invested Capital (ROIC) | 4.60% (35.29%) | 3.40% (-54.67%) | 7.50% (15.38%) | 6.50% (-18.75%) |
Dividend Yield | 2.20% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | 64.95 (42.22%) | 45.67 (113.81%) | 21.36 (-9.97%) | 23.73 (43.62%) |
Price to Sales Ratio (P/S) | 1.54 (-0.78%) | 1.55 (-7.86%) | 1.68 (9.88%) | 1.53 (-21.06%) |
Price to Book Ratio (P/B) | 1.01 (11.91%) | 0.91 (-14.84%) | 1.06 (10.94%) | 0.96 (-19.87%) |
Debt to Equity Ratio (D/E) | 1.05 (-2.14%) | 1.08 (-10.03%) | 1.2 (-9.25%) | 1.32 (-11.77%) |
Earnings Per Share (EPS) | 34.18 (-25.77%) | 46.05 (-54.92%) | 102.14 (38.84%) | 73.57 (-38.88%) |
Sales Per Share (SPS) | 9.68 (7.84%) | 8.97 (-8.51%) | 9.81 (4.76%) | 9.36 (-0.65%) |
Free Cash Flow Per Share (FCFPS) | 260.12 (48.53%) | 175.13 (-46.94%) | 330.06 (-9.64%) | 365.27 (-0.86%) |
Book Value Per Share (BVPS) | 2,187.48 (-5.63%) | 2,317.94 (13.11%) | 2,049.24 (12.75%) | 1,817.57 (9.47%) |
Tangible Assets Book Value Per Share (TABVPS) | 1,669.32 (-3.43%) | 1,728.61 (9.44%) | 1,579.43 (-0.27%) | 1,583.68 (-0.71%) |
Enterprise Value Over EBIT (EV/EBIT) | 31 (-29.55%) | 44 (120.00%) | 20 (-4.76%) | 21 (16.67%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 10.49 (-11.96%) | 11.92 (29.62%) | 9.19 (-3.26%) | 9.5 (0.16%) |
Asset Turnover | 0.3 (5.54%) | 0.29 (0.70%) | 0.29 (2.87%) | 0.28 (9.41%) |
Current Ratio | 1.01 (-9.04%) | 1.11 (14.49%) | 0.97 (-20.10%) | 1.21 (-20.98%) |
Dividends | ¥0.33 (0%) | ¥0 (0%) | ¥0 (0%) | ¥0 (0%) |
Free Cash Flow (FCF) | ¥824,681,000,000 (50.07%) | ¥549,530,000,000 (-46.30%) | ¥1,023,427,000,000 (-10.39%) | ¥1,142,091,000,000 (-0.50%) |
Enterprise Value (EV) | ¥80,559,514,912 (2.30%) | ¥78,751,208,915 (-6.21%) | ¥83,967,061,521 (2.35%) | ¥82,037,623,801 (-19.83%) |
Earnings Before Tax (EBT) | ¥174,869,000,000 (232.07%) | ¥52,661,000,000 (-85.96%) | ¥375,069,000,000 (24.00%) | ¥302,464,000,000 (-17.38%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | ¥1,146,330,000,000 (14.57%) | ¥1,000,513,000,000 (-17.26%) | ¥1,209,167,000,000 (14.92%) | ¥1,052,222,000,000 (-10.40%) |
Invested Capital | ¥7,686,005,000,000 (-7.71%) | ¥8,328,146,000,000 (19.25%) | ¥6,984,047,000,000 (0.25%) | ¥6,966,725,000,000 (-8.70%) |
Working Capital | ¥14,671,000,000 (-94.02%) | ¥245,477,000,000 (392.29%) | -¥83,984,000,000 (-118.75%) | ¥447,912,000,000 (-52.34%) |
Tangible Asset Value | ¥5,292,354,000,000 (-2.43%) | ¥5,424,043,000,000 (10.75%) | ¥4,897,370,000,000 (-1.10%) | ¥4,951,725,000,000 (-0.35%) |
Market Capitalization | ¥47,143,230,865 (8.17%) | ¥43,584,217,764 (-14.71%) | ¥51,099,891,276 (14.13%) | ¥44,774,577,674 (-21.30%) |
Average Equity | ¥7,268,132,250,000 (3.81%) | ¥7,001,650,500,000 (9.57%) | ¥6,389,965,250,000 (18.46%) | ¥5,394,135,500,000 (12.63%) |
Average Assets | ¥15,038,967,750,000 (1.97%) | ¥14,749,091,500,000 (5.13%) | ¥14,029,182,000,000 (9.83%) | ¥12,773,511,000,000 (1.73%) |
Invested Capital Average | ¥8,450,313,500,000 (5.28%) | ¥8,026,486,500,000 (9.80%) | ¥7,310,261,250,000 (1.50%) | ¥7,202,101,500,000 (-5.88%) |
Shares | 1,585,179,249 (1.04%) | 1,568,906,327 (1.20%) | 1,550,360,779 (-0.83%) | 1,563,358,159 (0.36%) |
